| [1] |
中华医学会神经病学分会神经遗传学组. 中国肝豆状核变性诊治指南2021[J]. 中华神经科杂志, 2021, 54(4): 310-319.
|
| [2] |
Członkowska A, Litwin T. Wilson disease-currently used anticopper therapy[J]. Handb Clin Neurol, 2017, 142: 183-191.
|
| [3] |
Fernando M, van Mourik I, Wassmer E, et al. Wilson disease in children and adolescents[J]. Arch Dis Child, 2020, 105(5): 499-505.
doi: 10.1136/archdischild-2018-315705
URL
|
| [4] |
Brewer GJ. The modern treatment of Wilson’s disease[J]. J G Astrointest Dig Syst, 2015, 5: 4.
|
| [5] |
Stremmel W. Bis-choline tetrathiomolybdate as old drug in a new design for Wilson’s disease: good for brain and liver?[J]. Hepatology, 2019, 69(2): 901-903.
doi: 10.1002/hep.30130
URL
|
| [6] |
Aggarwal A, Bhatt M. Advances in treatment of Wilson disease[J]. Tremor Other Hyperkinet Mov (N Y), 2018, 8: 525.
doi: 10.7916/D841881D
pmid: 29520330
|
| [7] |
Mulligan C, Bronstein JM. Wilson disease: an overview and approach to management[J]. Neurol Clin, 2020, 38(2): 417-432.
doi: S0733-8619(20)30005-0
pmid: 32279718
|
| [8] |
张杰, 喻绪恩, 艾文龙, 等. Wilson病过度驱铜致铜缺乏周围神经病一例并文献复习[J]. 中华神经科杂志, 2019, 52(11): 919-924.
|
| [9] |
黄丽, 李洵桦, 梁秀龄, 等. 影响肝豆状核变性患者预后及疗效因素的研究[J]. 中国神经精神疾病杂志, 2006, 32(1): 11-14.
|
| [10] |
周香雪, 李洵桦, 梁秀龄. 青霉胺治疗引起肝豆状核变性神经症状加重[J]. 中华神经科杂志, 2008, 41(10): 674-677.
|
| [11] |
Zhang JW, Liu JX, Hou HM, et al. Effects of tetrathiomolybdate and penicillamine on brain hydroxyl radical and free copper levels: a microdialysis study in vivo[J]. Biochem Biophys Res Commun, 2015, 458(1): 82-85.
doi: 10.1016/j.bbrc.2015.01.071
URL
|
| [12] |
Chen D, Zhou X, Hou H, et al. Clinical efficacy of combined sodium dimercaptopropanesulfonate and zinc treatment in neurological Wilson’s disease with D-penicillamine treatment failure[J]. Ther Adv Neurol Disord, 2016, 9(4): 310-316.
doi: 10.1177/1756285616641598
URL
|
| [13] |
Santiago R, Gottrand F, Debray D, et al. Zinc therapy for Wilson disease in children in French pediatric centers[J]. J Pediatr Gastroenterol Nutr, 2015, 61(6): 613-618.
doi: 10.1097/MPG.0000000000000926
URL
|
| [14] |
Hou H, Chen D, Liu J, et al. Zinc monotherapy for young patients with oligosymptomatic Wilson disease: a single center, retrospective study[J]. Clin Res Hepatol Gastroenterol, 2021, 45(6): 101623.
doi: 10.1016/j.clinre.2021.101623
URL
|
| [15] |
Litwin T, Dušek P, Członkowska A. Symptomatic treatment of neurologic symptoms in Wilson disease[J]. Handb Clin Neurol, 2017, 142: 211-223.
|
| [16] |
郭玄玄, 汪瀚, 杨文明. 肝豆状核变性肝胆湿热病机探讨[J]. 中医药临床杂志, 2018, 30(4): 624-627.
|
| [17] |
Moini M, To U, Schilsky ML. Recent advances in Wilson disease[J]. Transl Gastroenterol Hepatol, 2021, 6: 21.
doi: 10.21037/tgh-2020-02
URL
|
| [18] |
Rupp C, Stremmel W, Weiss KH. Novel perspectives on Wilson disease treatment[J]. Handb Clin Neurol, 2017, 142: 225-230.
|
| [19] |
Murillo O, Moreno D, Gazquez C, et al. Liver expression of a miniATP7B gene results in long-term restoration of copper homeostasis in a Wilson disease model in mice[J]. Hepatology, 2019, 70(1): 108-126.
doi: 10.1002/hep.30535
pmid: 30706949
|
